ClinicalTrials.gg
RecruitingNCT06652828TRAILUpdated May 14, 2025

Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients

An interventional study of Conventional Treadmill Walking (CTT) and Perturbation-Based Balance Training (PBT) in Fall Prevention, Exercise and Geriatrics, sponsored by University of Oldenburg. Recruiting at 3 sites in Germany. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2025-05-14.

Primary conditionCognitive DysfunctionRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Cognitive Dysfunction
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Cognitive Dysfunction.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Oldenburg · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
396
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 102 studies in Cognitive Dysfunction with a site in Germany — 20 open to participants now, 27 under way, 5 of them phase 3. Cognitive Dysfunction · Germany.

Planned enrollment
18th of 75
396 · median 100
Started
2024
with 4 others
No phase
42 of 102
11 open now
Primary completion
2027-04
later than 11 of 26 live
Registered
85th of 102
by date

Among the 102 studies in Cognitive Dysfunction with a site in Germany, this one is the 18th largest by planned enrollment of the 75 interventional ones that give a count, is one of 5 that started in 2024, is one of 42 with no phase, reaches primary completion later than 11 of the 26 other live ones, and was the 85th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

20 of the 102 studies in Cognitive Dysfunction with a site in Germany are open now. Recruiting first, the newest first:

14 more — sign in →

All 20 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 70 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 102 studies in Cognitive Dysfunction with a site in Germany, or all of them as a file.
02

Study summary

The goal of this clinical trial is to determine the effectiveness of perturbation-based balance training (PBT) in preventing unrecovered falls among geriatric patients aged ≥70 years with a prospective fall risk of ≥40%. The study will also assess the safety and feasibility of PBT. The main research questions are:

A total of 396 participants will receive 9 training sessions of either PBT or conventional treadmill training and will attend an assessment before and after the intervention, as well as 6 and 12 months follow up. Falls will be documented throughout the entire study period using calendars, telephone interviews, and proxy information. The primary outcome, unrecovered falls, will be recorded after the end of the intervention until 12 months follow up.

Read the detailed description

Falls are common and the leading cause of injuries among older adults, but falls may be attenuated by the promising and time-efficient intervention called perturbation-based balance training (PBT). The aim of the TRAIL-study is to confirm the effectiveness of a treadmill PBT protocol for preventing unrecovered falls in geriatric patients with and without cognitive impairment. This study is designed as a confirmatory, multicenter, assessor-blinded, randomized controlled study. The 396 geriatric patients aged ≥70 years with ≥40% prospective fall risk and being capable of walking ≥70 m in a 2-Minute Walk Test will receive 9 sessions of PBT on a treadmill (intervention) or a conventional treadmill training (control group; CTT).

Outcome assessments will be performed shortly after the intervention interval as well as 6 and 12 months thereafter. The primary outcome is defined as unrecovered falls (defined as falls in which persons who fell are unable to get up independently) within 12-month follow-up. Falls are documented over at least 12 months using calendars, telephone interviews, and proxy information. Secondary outcomes include mobility, balance performance, concerns about falling, physical activity and capacity, stepping responses, health-related quality of life, cognitive functioning, mobility, reactive dynamic balance and training acceptability of PBT. The study will be accompanied by a patient advisory board and an expert advisory board and focus groups will be conducted to involve the target group.

Based on pilot studies and the available literature, we expect a ≥50% reduction of unrecovered falls during the following year in the intervention group (PBT) compared to the control group (CTT).

03

Conditions studied

  • Fall Prevention
  • Exercise
  • Geriatrics
  • Cognitive Impairment
  • Perturbation

Browse trials for

Keywords

  • treadmill
  • unrecovered falls
  • fall risk
  • training
  • falls
  • balance
  • rehabilitaion
04

In context

Cognitive Dysfunction Reclassified

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

This study's planned enrollment of 396 is above the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

University of Oldenburg is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Compared within Cognitive Dysfunction, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 70 years
  • ≥40% prospective fall risk for the following year according to the Fall Risk Assessment Tool (FRAT-up)
  • Walking distance ≥ 70 m in the 2 Minute Walk Test
  • Possibility to reach the study site at least via taxi
  • Written , obtained according to international guidelines and local laws

Exclusion criteria

Exclusion Criteria:

  • score \< 10 pts (or MMSE \< 17 pts)
  • Performing a Timed up and Go test (TUG) \<10 s
  • Leg amputation
  • Osteosynthesis or joint replacement of lower extremities within the past 6 weeks.
  • Blindness
  • Parkinson's disease with Hoehn and Yahr stage > 3
  • Body weight >135 kg and height >185 cm
  • Life-expectancy \<12 months, instable or severe illness
  • Inability to communicate verbally and coorporate appropriatly
  • (Prior) participation perturbation training programs
  • Gait-relevant foot-drop paresis
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
396 participants (estimated)

Study arms

  • Active comparator
    Conventional Treadmill Training (CTT)

    Other: Conventional Treadmill Walking (CTT)

  • Experimental
    Perturbation-Based Balance Training (PBT)

    Other: Perturbation-Based Balance Training (PBT)

Interventions

  • OtherConventional Treadmill Walking (CTT)

    The CTT serves as a comparison to PBT. It involves standard treadmill walking without perturbations on the same treadmill. This intervention is conducted over the same defined period as PBT (3-6 weeks), with a matched frequency and exercise time compared to the PBT group for consistency. Participants are secured with safety harnesses while walking.

    Also known as: Exercise intervention

  • OtherPerturbation-Based Balance Training (PBT)

    Overall, 9 training sessions with different objectives and progression regarding perturbation directions, predictability, and intensity will be conducted within 3-6 weeks. During the initial sessions, familiarizing participants with the treadmill and establishing their individual walking pace will be focused. Pace can be individually adjusted in each training session. Participants are secured with safety harnesses while walking.

    Also known as: Gait adaptability training, Reactive balance training

07

What researchers measure

Primary outcomes

  1. Rate of unrecovered falls

    Falls are assessed using fall calendars, telephone interviews, and proxy information.

    Time frame: Continuously from intervention end until 12 months after the end of the intervention

Secondary outcomes

  1. Rate of falls

    Falls are assessed using fall calenders, telephone interviews, and proxy information.

    Time frame: Continuously from intervention end until 12 months after the end of the intervention

  2. Physical activity

    Physical activity will be measured over 7 days using a body-fixed inertial measurement unit (AX6, Axivity Ltd., Newcastle, UK) , which will be placed at lumbar level (L5) of the participant. The sensor measures linear acceleration data in 3 dimensions in combination with angular data. From these data, besides others, time spent with physical activity, steps as well as time spent in the supine sitting or standing position can be determined and reported. Data will be used to describe the participants and to report falls per physical activity.

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  3. Stepping response (a)

    Modified Stepping Threshold Tests (i.e. single step, multiple step threshold). Participants will experience suface perturbations in ante-posterior as well as mediolateral direction with increasing intensity until they have to perform a single compensatory step or multiple steps to recover balance. Higher perturbation levels for the single or multiple step threshold indicate better static reactive balance.

    Time frame: 12 months after the intervention

  4. Stepping reponse (b)

    Choice Stepping Reaction Test

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  5. Cognitive functioning (a)

    Montreal Cognitive Assessment (MoCA). Minimum value: 0 points; Maximum value: 30 points; higher values indicate better cognitive functioning.

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), and 12 months after the intervention

  6. Cognitive functioning (b)

    TMT (Trail Making Test)

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  7. Concerns about falling

    Short Falls Efficacy Scale International (Short FES-I). Minimum value: 7 points, Maximum value: 28 points; higher values indicate more concerns about falling.

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  8. Health-related quality of life

    Euro Quality of Life with visual analogue scales (EQ-VAS), values of 0-100: lower values indicate worse subjective health; EuroQol 5-Dimensions 5-Levels

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  9. Physical capacity (a)

    2MWT (2 Minute Walk Test )

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  10. Physical capacity (b)

    SPPB (Short Physical Performance Battery), including balance, leg strength and gait speed; minimum value: 0 points; maximum value: 12 points; higher values indicate better physical capacity.

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  11. Physical capacity (c)

    TUG (Timed "Up and Go"-Test)

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

  12. Nutritional status

    MNA (Mini Nutritional Assessment); values of 0-30: lower values indicate worse nutritional status

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), 6 months after the intervention, and 12 months after the intervention

  13. Reactive dynamic balance (a)

    Adapted Compensatory Arm and Leg Movements after perturbations induced on the treadmill during walking. Minimum value: 16 points; Maximum value: 108 points; higher values indicate better reactive dynamic balance.

    Time frame: 3rd (during the on average 1st week of the intervention) and last training session (during the on average 3rd week, at maximum 6th week of the intervention) (intervention group only), and 12 months after the intervention (intervention and control group)

  14. Reactive dynamic balance (b)

    Spatio-temporal, kinematic and stability parameters (video-based, inertial measurement units and center of pressure data)

    Time frame: 3rd (during the on average 1st week of the intervention) and last training session (during the on average 3rd week, at maximum 6th week of the intervention) (intervention group only), and 12 months after the intervention (intervention and control group)

  15. Laboratory falls

    Falls after perturbations on the treadmill. A fall is determined based on video recordings. A fall is defined as unambiguous support by the safety harness after the perturbation.

    Time frame: during 3rd (on average 1st week of the intervention) and last training session (on average 3rd week, at maximum 6th week of the intervention; intervention group only), and 12 months after the intervention (intervention and control group)

  16. Acceptability of PBT

    Theoretical Framework of Acceptability-based Questionnaire

    Time frame: during the last training session (during the on average 3rd week, at maximum 6th week of the intervention, in the intervention group only)

  17. Vibration sensation

    Vibration measurement at the inner ankle using a tuning fork. Minimum value: 1 point, Maximum value: 8 points; higher values indicate higher sensation

    Time frame: Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention

Other outcomes

  1. Assessment of safety

    Intervention-related adverse events

    Time frame: Continuously from baseline assessment until 12 months after the end of the intervention (intervention starts at maximum 4 weeks after baseline assessment)

08

Study locations

3 of 3 sites recruiting
  • Geriatric Center, Heidelberg University Hospital, Agaplesion Bethanien Krankenhaus
    Heidelberg, Baden-Württemberg 69126, Germany
    Recruiting
  • Department of Geriatric Medicine, University Hospital Marien Hospital Herne - Ruhr-University Bochum
    Herne, Nordrhein-Westfalen 44625, Germany
    Recruiting
  • Carl von Ossietzky Universität, Department für Versorgungsforschung, Abteilung Geriatrie
    Oldenburg, 26129, Germany
    Recruiting
    • Tania Zieschang, Prof. Dr. med. · Contacttania.zieschang@uol.de · +49 441 798-4760
    • Jessica Koschate-Storm, PD Dr. · Contactjessica.koschate-storm@uol.de · +49 441 798-4760
    • Tania Zieschang, Prof. Dr. med. · Principal investigator
    • Jessica Koschate-Storm, PD Dr. · Sub investigator
09

References and documents

Related links

Individual participant data

Plan to share: Yes — Data will be made available upon reasonable request via e-mail.

Supporting information: Study protocol

Time frame: The data will be available for 10 years after the last publication of the study results.

Access criteria: Data will be made available upon reasonable request via e-mail.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Apr 2027, 29 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 29 months is close to that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2024
First posted
Oct 22, 2024
StartActual
Nov 25, 2024
Primary completionEst.
Apr 30, 2027
CompletionEst.
Apr 30, 2027
Last update
May 14, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06652828
Lead sponsor
University of Oldenburg
Collaborators
Marienhospital Herne, University of Ulm, University of Konstanz, University Hospital RWTH Aachen University, Aachen, Germany., Robert Bosch-Krankenhaus Stuttgart, Heidelberg University Hospital, Heidelberg, Germany, Technische Hochschule Ulm
Responsible party
Prof. Dr. med. Tania Zieschang (Prof. Dr. med., University of Oldenburg) — Principal investigator
First posted
Oct 22, 2024
Start date
Nov 25, 2024
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
May 14, 2025

Study contacts

Tania Prof. Dr. med. Zieschang
Contact
tania.zieschang@uol.de
+49 441 798-4760
Jessica PD Dr. Koschate-Storm
Contact
jessica.koschate-storm@uol.de
+49 441 798-4760
Tania Zieschang, Prof. Dr. med.
principal investigator · Carl von Ossietzky University Oldenburg

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion